Drug Channels Institute (DCI) is a leading source of industry research about pharmaceutical economics and the drug distribution system. >

Industry Reports

The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

The ultimate guide to the complex web of interactions within the U.S. prescription distribution and reimbursement system more >

The 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

The most comprehensive tool for analyzing the economic and business realities of the U.S. pharmaceutical distribution industry. more >

From The Drug Channels Blog

Transparency is No Longer a Compliance Issue

Today's guest post comes from Meghal Patel, Chief Product Officer for Truzo at Model N. Meghal examines why claims-level transparency has become increasingly important as manufacturers navigate the growing more >

The IRA Fixed One Medicare Part D Distortion—But Patients Now Face New Tradeoffs (rerun)

This week, we're rerunning some popular posts while we put the finishing touches on DCI’s 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Click here more >